Novozymes Biopharma secures business award

Novozymes Biopharma UK has received the 2011 Nottingham Evening Post (NEP) Business Award in the business innovation category, for its recombinant human albumin range and in recognition of its contribution in development of process improving solutions for the medical device and pharmaceutical manufacturing industries.

The NEP business awards are designed to reward organisations in the region for setting new benchmarks in their industries and the company was delighted to receive the accolade.

“Novozymes Biopharma is pleased to have been selected for the business innovation award”, commented Sally Vernon, Customer Communications Manager,Novozymes Biopharma.

“We have a great infrastructure in the business and a dedication to science which is what makes us important to our customers. We are committed to working with customers to improve their products and processes and with the large pharmaceutical companies looking to reformulate many of their patents,we can support them by giving them the edge over their competitors.” The company offers long-term supply and large volume quantities of animal-free products including recombinant human albumin.